Zummo Jacqueline
Chief R&D Officer at TARA
- Sold, on record
- $221k
- Dollars the filings state
- Form 4 sales
- 3
- Latest Apr 8, 2026
- Form 144 notices
- 1
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- TARAProtara Therapeutics, Inc.Chief R&D Officer
Sales by reason
0
Routine
0
Plan not stated
2
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice TARANoticeMar 26, 2025 2025
Filed to sell 21,224 shares ($97k)
Zummo Jacqueline, Officer
10b5-1 planFirst sale on recordFiling
- 2 Form 4 sale TARARoutineMar 26, 2025 same day
Sold 21,224 shares at $4.53 ($96k)
Zummo Jacqueline, Chf Scientific Operations Off
10b5-1 planSold 17.7% of holdings ($544k position)98,861 shares leftFirst sale on recordFollows a Form 144Filing
- 3 Form 4 sale TARANo planApr 1, 2026 +371 days
Sold 22,598 shares at $5.26 ($119k)
Zummo Jacqueline, Chief R&D Officer
No 10b5-1 planSold 19.1% of holdings ($624k position)95,961 shares leftFiling
- 4 Form 4 sale TARANo planApr 8, 2026 +7 days
Sold 1,134 shares at $5.40 ($6k)
Zummo Jacqueline, Chief R&D Officer
No 10b5-1 planSold 1.2% of holdings ($518k position)94,827 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Apr 8, 2026 | Apr 9, 2026 | TARA | Chief R&D Officer | Form 4 sale | 1,134 | $6k | 1.2% | No plan | SEC |
| Apr 1, 2026 | Apr 2, 2026 | TARA | Chief R&D Officer | Form 4 sale | 22,598 | $119k | 19.1% | No plan | SEC |
| Mar 26, 2025 | Mar 28, 2025 | TARA | Chf Scientific Operations Off | Form 4 sale | 21,224 | $96k | 17.7% | Routine | SEC |
| Mar 26, 2025 | Mar 26, 2025 | TARA | Officer | Form 144 notice | 21,224 | $97k | Notice | SEC |